title: Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
abstract: The chemokine receptor 4 (CXCR4) has been widely used in diagnosis and prognosis of colorectal cancer (CRC). However, there is no current consensus on the impact of CXCR4 on CRC patients. The purpose of this study was to evaluate the prognostic and clinicopathological importance of CXCR4 in CRC patients. Databases, such as PubMed, Cochrane library, CBM and EMBASE updated to 2014 were searched to include eligible articles. We analysed correlations between CXCR4 expression and clinicopathological features and overall survival (OS). A total of 1, 055 CRC patients from twelve studies were included in the study. The pooled odds ratios (ORs) which indicated CXCR4 expression was likely to be associated with TNM stage (OR=0.43, CI=0.34-0.55, P<0.00001), lymph node status (OR=2.23, CI=1.23-4.05, P=0.008) and vascular invasion (OR=2.21, CI=1.11-4.39, P=0.02). Poor overall survival of CRC cancer was found to be significantly related to CXCR4 overexpression (hazard ratio (HR) 1.36 CI=1.17-1.59, P<0.0001), whereas combined ORs revealed that CXCR4 expression had no correlation with gender or differentiation. Based on the published studies, CXCR4 overexpression in patients with CRC indicates poor survival outcome and clinicopathological factors.
authors.affiliation: Department of Gastroenterology, Linyi People's Hospital, Linyi, China E-mail : Wjingsmile123@126.com.
authors.forename: Lu-Ning
authors.initials: LN
authors.lastname: Li
authors.forename: Kai-Tong
authors.initials: KT
authors.lastname: Jiang
authors.forename: Peng
authors.initials: P
authors.lastname: Tan
authors.forename: Ai-Hua
authors.initials: AH
authors.lastname: Wang
authors.forename: Qing-Yin
authors.initials: QY
authors.lastname: Kong
authors.forename: Cui-Yue
authors.initials: CY
authors.lastname: Wang
authors.forename: Hua-Rong
authors.initials: HR
authors.lastname: Lu
authors.forename: Jing
authors.initials: J
authors.lastname: Wang
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D019718:Receptors, CXCR4 / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; C527276:CXCR4 protein, human; D019718:Receptors, CXCR4